References
- USP Official. (2008). General Chapters: 905 Uniformity of Dosage Units.
- U.S. Department of Health and Human Services, Food, and Drug Administration, Center for Drug Evaluation, Research. (2003). Guidance for Industry: Powder Blends and Finished Dosage Units-Stratified In-Process Dosage Unit Sampling and Assessment.
- Senderak ET. (2009). Content uniformity acceptance limit for a validation batch–suppositories, transdermal systems, and inhalations. Drug Dev Ind Pharm, 35:735–737.
- US vs. Barr Laboratories. (1993). 812, F. Supp 458, D.N.J.
- Son YJ, McConville JT. (2008). Advancements in dry powder delivery to the lung. Drug Dev Ind Pharm, 34:948–959.
- Medendorp J, Donovan B, Pennington J. (2010). Development of a high-throughput UHPLC-MS-based content uniformity method as a tool for assessing dry powder inhalers. Drug Dev Ind Pharm, 36:762–772.
- Pennington J. (2010). Determination of content uniformity for dry powder inhaler formulations: UHPLC-MS based mathematical modeling approach as a PAT tool. Respir Drug Deliv 3:667–670.
- Karpel JP. (2000). An easy-to-use dry-powder inhaler. Adv Ther, 17:282–286.
- Brewer E, Ramsland A. (1995). Particle size determination by automated microscopical imaging analysis with comparison to laser diffraction. J Pharm Sci, 84:499–501.
- Berman J. (2001). The compliance and science of Blend Uniformity Analysis. PDA J Pharm Sci Technol, 55:209–222.